These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 662655)

  • 21. [Frequency, diagnosis, and course of hepatotoxic side effects of Rifampicin (author's transl)].
    Deck KA; Gehrhardt A; Klein HO; Ludes H
    Med Klin; 1976 Oct; 71(43):1836-41. PubMed ID: 995024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].
    Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H; Werner E; Winsel K; Iwainsky H
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
    [No Abstract]   [Full Text] [Related]  

  • 24. Isoniazid plus rifampicin in the initial treatment of pulmonary tuberculosis.
    Clarke GB; Cuthbert J; Cuthbert RJ; Lees AW
    Br J Dis Chest; 1972 Oct; 66(4):268-71. PubMed ID: 5083434
    [No Abstract]   [Full Text] [Related]  

  • 25. The disposition of antituberculous drugs in plasma of elderly patients. II. Isoniazid, rifampicin and pyrazinamide.
    Walubo A; Chan K; Woo J; Chan HS; Wong CL
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):551-6. PubMed ID: 1956210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Isoniazid acetylation in a group of Tunisian patients. Report of 620 patients].
    Mehiri BR; Zouaoui A; Chérif J; Ourari B; Daghfous R; Oueslati MH; Louzir B; Daghfous J; Chelbi B; Béji M
    Tunis Med; 2005 Jul; 83(7):385-9. PubMed ID: 16220693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis.
    Linna O; Uhari M
    Eur J Pediatr; 1980 Sep; 134(3):227-9. PubMed ID: 6968680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Late results of treatment with rifampicin combined with SM and INH in newly detected cases of pulmonary tuberculosis].
    Szymański A
    Pneumonol Pol; 1976 Mar; 44(3):227-35. PubMed ID: 1257096
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rate of acetylation of isoniazid in pulmonary tuberculosis and its relationship with effect and side-effects of treatment (author's transl)].
    Zhang LX
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Dec; 4(6):349-51. PubMed ID: 7344873
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of rifampicin and isoniazid on liver function.
    Lal S; Singhal SN; Burley DM; Crossley G
    Br Med J; 1972 Jan; 1(5793):148-50. PubMed ID: 5007842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of acetyl hydrazines and rate of acetylation of isoniazid in adult tuberculosis patients.
    Bhalerao EB; Bhide SV
    Indian J Physiol Pharmacol; 1985; 29(2):83-8. PubMed ID: 4093196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 33. Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
    Nijland HM; Ruslami R; Suroto AJ; Burger DM; Alisjahbana B; van Crevel R; Aarnoutse RE
    Clin Infect Dis; 2007 Oct; 45(8):1001-7. PubMed ID: 17879915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Initial pulmonary tuberculosis treated with the isoniazid-rifampicin combination and followed after cessation of treatment].
    Oury M; Tuchais E; Viallet S; Chauvet G
    Rev Tuberc Pneumol (Paris); 1971 Dec; 35(8):819-28. PubMed ID: 5151119
    [No Abstract]   [Full Text] [Related]  

  • 35. Single dose kinetics of rifampicin and isoniazid in well-nourished and malnourished patients of tuberculosis.
    Garg SK; Dhand R; Malik SK; Kalra S; Gupta PH; Jha VK; Shukla VK; Lal R
    Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):417-20. PubMed ID: 3220617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sequential development of vitamin D metabolites under isoniazid and rifampicin therapy].
    Toppet M; Vainsel M; Vertongen F; Fuss M; Cantraine F
    Arch Fr Pediatr; 1988 Feb; 45(2):145-8. PubMed ID: 2898926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of the phenotype of INH inactivation in pulmonary tuberculosis by means of an indirect method on the model of sulfamethazine].
    Powłowska I; Rakowska Z
    Pneumonol Pol; 1978 Aug; 46(8):605-12. PubMed ID: 714703
    [No Abstract]   [Full Text] [Related]  

  • 38. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The pharmacokinetics of isoniazid in children (author's transl)].
    Advenier C; Saint-Aubin A; Scheinmann P; Paupe J
    Rev Fr Mal Respir; 1981; 9(5):365-74. PubMed ID: 7323401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Indicators of INH inactivation determined using a biological method and its use in monitoring antitubercular treatment].
    Czaplińska-Jóźwiak E; Szymański A; Dutkiewicz J
    Pneumonol Pol; 1986 Dec; 54(12):535-40. PubMed ID: 3588330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.